MYL5 can induce gene expression in cervical cancer by binding to the AGCTCC promoter by the HIF-1 start site, upregulating HIF-1 in CC, and increasing cells’ invasive abilities [27]. This evidence concerns the gene MYL5 and cervical cancer.